Advances in Oral Drugs for Multiple Sclerosis
Today, Teva Pharmaceuticals had mixed reports to share regarding laquinimod, an experimental, oral drug for Multiple Sclerosis.
Click here to read more about the clinical study and other oral treatments for Multiple Sclerosis.
Press + Media
- Print Press Coverage
- TV Press Coverage
- Online Press Coverage
- Foundation Videos
- Foundation Blog
- Press Materials
Topics of Interest
Posted: Dec 04, 2013An anti-tuberculosis vaccine could prevent multiple sclerosis, early research suggests. The vaccine and a placebo were tested ...
Posted: Sep 24, 2013Taking place at the Hyatt Regency Century City on December ...
Posted: Jun 12, 2013The 2012-2013 Virtual Race to Erase MS raised around $30,000 ...
Posted: Jan 10, 2013We are excited to share the official theme, *Love to ...